PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: biology

1151 PHARMACEUTICAL DOSAGE FORMS

Printed on: Fri May 14 2021, 10:26:22 AM Official Status: Currently Official on 14-May-2021 DocId: 1_GUID-431F93A9-1 FEC-42AE-8556-AA5B604B2E36_8_en-US. (EST). Printed by: Deborah Nishikawa Official Date: Official as of 01-May-2021 Document Type: GENERAL CHAPTER @2021 USPC. 1. 1151 PHARMACEUTICAL DOSAGE FORMS . Change to read: GENERAL CONSIDERATIONS. This chapter provides general descriptions of and definitions for drug products, or DOSAGE FORMS , commonly used to administer the drug substance (active PHARMACEUTICAL ingredient; API). It discusses general principles involved in the manufacture or compounding of these DOSAGE FORMS .

that observed or anticipated for an immediate-release dosage form. Expressions such as “prolonged-release”, “repeat-action”, “controlled-release”, “long-acting”, and “sustained-release” also have been used to describe such dosage forms. However, the term “extended-release” is used for official article titles.

Fullscreen Download
Loading..

Tags:

  Form, Release, Dosage, Dosage forms, Release dosage

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of 1151 PHARMACEUTICAL DOSAGE FORMS

Documents from same domain

1117 MICROBIOLOGICAL BEST LABORATORY PRACTICES

latam-edu.usp.org

Whenever possible, sampling equipment should be loaded with its microbiological recovery media in the environment that is to be sampled. All testing in laboratories used for critical testing procedures, such as sterility testing of final dosage forms, bulk product, seed

  Microbiological, Sampling

USP <51> Antimicrobial Effectiveness Testing

latam-edu.usp.org

If the diluted product exhibits antimicrobial properties, specific neutralizers may need to be incorporated into the diluents or the recovery media. The ability of the procedure to measure preservative efficacy may be compromised if the method suitability requires significant dilution (10 −2 or 10 −3) as this will affect the measured recovery

  Testing, Effectiveness, Antimicrobial, Efficacy, Usp lt 51 gt antimicrobial effectiveness testing

1664 〉〉〉〉 ASSESSMENT OF DRUG PRODUCT …

latam-edu.usp.org

administration ports, overwraps, adminstration accessories, labels, cardboard boxes, and shrink wrap. A Primary Packaging Component is in direct contact or may come into direct contact with the product (e.g., IV bag). A Secondary Packaging Component is in direct contact with a primary packaging component and may provide additional protection

  Packaging, Shrink

659 PACKAGING AND STORAGE REQUIREMENTS

latam-edu.usp.org

Ancillary component:A component or entity that may come into contact with a Tertiary packaging component during the distribution, storage, and/or transportation of the packaged article (e.g., pallets, skids, and shrink wrap).

  Packaging, Shrink

Module 08 USP 1115 Bioburden Control of Non-Sterile …

latam-edu.usp.org

Unlike aseptic processing for which facility requirements are generally uniform in specification and performance, nonsterile product manufacturing environments typically involve diverse products and microbial contamination control requirements. In general, liquid, cream, or ointment products require a greater level of

  Product, Control, Sterile, Aseptic, Bioburden, Bioburden control of non sterile

USP <71> Sterility Tests - United States Pharmacopeia

latam-edu.usp.org

The view from USP <1211> Sterilization and Sterility Assurance of Compendial Articles : 6 ... For products containing a mercurial preservative that cannot be tested by the ... Used for sterility testing of viscous products and for devices having tubes with small lumen.

  Product, Tests, Assurance, Sterility, Sterility assurance, Usp lt 71 gt sterility tests

71 〉〉〉〉 STERILITY TESTS

latam-edu.usp.org

of the test. Modify the conditions in order to eliminate the antimicrobial activity, and repeat the Method Suitability Test. This method suitability is performed (a) when the test for sterility has to be carried out on a new product; and (b) whenever there is a change in the experimental conditions of the test.

  Tests, Activity, Antimicrobial, Antimicrobial activity

1092 THE DISSOLUTION PROCEDURE: DEVELOPMENT AND …

latam-edu.usp.org

5.4 Precision 5.4.1 Repeatability of Analysis 5.4.2 Intermediate Precision/Ruggedness 5.4.3 Reproducibility 5.5 Robustness 5.6 Stability of Standard and Sample Solutions ... (such as dynamic solubility, potentiometric titration, or turbidity measurement methods). (USP …

  Precision, Potentiometric

STERILIZATION OF COMPENDIAL ARTICLES

latam-edu.usp.org

For steam and dry heat, the D-value is a function of temperature. In gas sterilization (ethylene oxide, ClO , or O ), D-values are a function of the chemical concentration, relative humidity, and temperature. Similarly, for liquid chemical sterilization the D-value is a function of the temperature and sterilant concentration.

  Steam, Sterilization

660 〉〉 CONTAINERS—GLASS

latam-edu.usp.org

glass containers will raise the hydrolytic resistance from a moderate to a high level, changing the classification of the glass to Type II. The following recommendations can be made as to the suitability of the glass type for containers for pharmaceutical products, based on the tests for hydrolytic resistance.

  Glass, Container, Containers glass

Related documents

Guideline on the pharmacokinetic and clinical evaluation ...

www.ema.europa.eu

Prolonged release dosage forms are modified release dosage forms showing a sustained release compared to that of an immediate release dosage form administered by the same route. • Delayed release dosage form: The release of the active substance from such modified release dosage forms is delayed for a certain period after administration or ...

  Form, Release, Dosage, Release dosage forms, Release dosage

Pharmaceutical Dosage Forms - Temple University

pharmacy.temple.edu

modified-release solid oral dosage forms encompass delayed/enteric-coated and extended-release drug products. Besides the delayed- and/or extended-release features, other newer types of oral modified-release products may include pulsatile …

  Form, Release, Dosage, Dosage forms

PROPOSAL TO WAIVE IN VIVO BIOEQUIVALENCE …

www.who.int

immediate release, solid oral dosage forms Deadline Consolidation of first list for consideration of biowaiver October 2004 Consolidation of comments March 2005 Discussion during consultation July 2005 Additional studies and review August-September 2005 Mailing of revised version for comments September 2005

  Form, Release, Dosage, Dosage forms

HIGHLIGHTS OF PRESCRIBING INFORMATION • In linezolid-or ...

pi.lilly.com

-----DOSAGE FORMS AND STRENGTHS-----Delayed-release capsules: 20 mg, 30 mg, and 60 mg (3)-----CONTRAINDICATIONS-----• Concomitant use of an MAOI antidepressant with CYMBALTA is contraindicated • Use of CYMBALTA within 14 days of stopping an MAOI antidepressant is contraindicated ...

  Form, Release, Dosage, Dosage forms, Cymbalta

2.9.3. DISSOLUTION TEST FOR SOLID DOSAGE FORMS

www.uspbpep.com

2.9.3. Dissolution test for solid dosage forms EUROPEAN PHARMACOPOEIA 6.0 beaker with a capacity of at least 4 litres filled with water maintained at 36-37 °C, unless otherwise prescribed. The apparatuses may also be placed together in a vessel with a capacity of …

  Form, Dosage, Dosage forms

ICH HARMONISED TRIPARTITE GUIDELINE

database.ich.org

and release for public consultation. 19 May 2011 Current Step 4 version Code History Date Q11 ... substance can affect the choice of dosage form). The Quality Target Product Profile (QTPP), potential CQAs of the drug product (as defined in ICH Q8) and previous ...

  Release, Dosage

Dosage Form Design: Pharmaceutical and Formulation ...

downloads.lww.com

ingredients or excipients, produces dosage forms of various types. The pharmaceutical ingredients solubilize, suspend, thicken, dilute, emulsify, sta-bilize, preserve, color, fl avor, and fashion medici-nal agents into effi cacious and appealing dosage forms. Each type of dosage form is unique in its physical and pharmaceutical characteristics.

  Form, Dosage, Dosage forms

Related search queries

Release dosage forms, Release, Release dosage, Dosage forms, CYMBALTA, Dosage